359 related articles for article (PubMed ID: 24968134)
1. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
2. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
3. The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats.
Batenburg WW; van den Heuvel M; van Esch JH; van Veghel R; Garrelds IM; Leijten F; Danser AH
J Hypertens; 2013 Feb; 31(2):292-302. PubMed ID: 23303354
[TBL] [Abstract][Full Text] [Related]
4. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
[TBL] [Abstract][Full Text] [Related]
5. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
Feldt S; Batenburg WW; Mazak I; Maschke U; Wellner M; Kvakan H; Dechend R; Fiebeler A; Burckle C; Contrepas A; Jan Danser AH; Bader M; Nguyen G; Luft FC; Muller DN
Hypertension; 2008 Mar; 51(3):682-8. PubMed ID: 18212269
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
[TBL] [Abstract][Full Text] [Related]
7. Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury.
Tenkumo K; Hirooka K; Sherajee SJ; Nakamura T; Itano T; Nitta E; Fujita T; Nishiyama A; Shiraga F
Exp Eye Res; 2014 May; 122():110-8. PubMed ID: 24709336
[TBL] [Abstract][Full Text] [Related]
8. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.
Feldt S; Maschke U; Dechend R; Luft FC; Muller DN
J Am Soc Nephrol; 2008 Apr; 19(4):743-8. PubMed ID: 18235083
[TBL] [Abstract][Full Text] [Related]
9. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.
Wilkinson-Berka JL; Tan G; Binger KJ; Sutton L; McMaster K; Deliyanti D; Perera G; Campbell DJ; Miller AG
Diabetologia; 2011 Oct; 54(10):2724-35. PubMed ID: 21755314
[TBL] [Abstract][Full Text] [Related]
11. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
Batenburg WW; de Bruin RJ; van Gool JM; Müller DN; Bader M; Nguyen G; Danser AH
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1151-7. PubMed ID: 18388329
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro.
Biswas KB; Nabi AH; Arai Y; Nakagawa T; Ebihara A; Ichihara A; Watanabe T; Inagami T; Suzuki F
Hypertens Res; 2010 Oct; 33(10):1053-9. PubMed ID: 20664543
[TBL] [Abstract][Full Text] [Related]
14. Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
Thomas CM; Yong QC; Seqqat R; Chandel N; Feldman DL; Baker KM; Kumar R
Clin Sci (Lond); 2013 Apr; 124(8):529-41. PubMed ID: 23116220
[TBL] [Abstract][Full Text] [Related]
15. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Prasad T; Roksnoer LC; Zhu P; Verma A; Li Y; Batenburg WW; de Vries R; Danser AH; Li Q
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6722-6730. PubMed ID: 27951594
[TBL] [Abstract][Full Text] [Related]
16. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.
Muller DN; Klanke B; Feldt S; Cordasic N; Hartner A; Schmieder RE; Luft FC; Hilgers KF
Hypertension; 2008 Mar; 51(3):676-81. PubMed ID: 18212268
[TBL] [Abstract][Full Text] [Related]
17. RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina.
Wilkinson-Berka JL; Heine R; Tan G; Cooper ME; Hatzopoulos KM; Fletcher EL; Binger KJ; Campbell DJ; Miller AG
Hypertension; 2010 Jun; 55(6):1454-60. PubMed ID: 20368504
[TBL] [Abstract][Full Text] [Related]
18. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
Schefe JH; Neumann C; Goebel M; Danser J; Kirsch S; Gust R; Kintscher U; Unger T; Funke-Kaiser H
J Hypertens; 2008 Sep; 26(9):1787-94. PubMed ID: 18698213
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptor.
Lu X; Krop M; Batenburg WW; Musterd-Bhaggoe UM; Garrelds IM; Danser AH
J Hypertens; 2014 Jun; 32(6):1255-63. PubMed ID: 24637873
[TBL] [Abstract][Full Text] [Related]
20. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy.
Hase K; Kanda A; Hirose I; Noda K; Ishida S
PLoS One; 2017; 12(12):e0189696. PubMed ID: 29240802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
